Shares of Creo Medical Group PLC (LON:CREO – Get Free Report) were down 2.8% on Monday . The stock traded as low as GBX 34 ($0.42) and last traded at GBX 34.25 ($0.43). Approximately 443,396 shares were traded during trading, a decline of 45% from the average daily volume of 809,068 shares. The stock had previously closed at GBX 35.25 ($0.44).
Creo Medical Group Trading Down 2.8 %
The company has a debt-to-equity ratio of 13.33, a current ratio of 4.13 and a quick ratio of 2.19. The business has a fifty day moving average of GBX 35.27 and a 200-day moving average of GBX 36.17. The stock has a market capitalization of £123.81 million, a price-to-earnings ratio of -311.36 and a beta of 0.84.
Creo Medical Group Company Profile
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
See Also
- Five stocks we like better than Creo Medical Group
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- The Charles Schwab Company Can Hit New Highs
- 3 Monster Growth Stocks to Buy Now
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
